p27–p16 Chimera: A Superior Antiproliferative for the Prevention of Neointimal Hyperplasia
Open Access
- 1 January 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (1) , 8-13
- https://doi.org/10.1006/mthe.2000.0239
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cancer Cell CyclesScience, 1996
- Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.Molecular Biology of the Cell, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Novel INK4 Proteins, p19 and p18, Are Specific Inhibitors of the Cyclin D-Dependent Kinases CDK4 and CDK6Molecular and Cellular Biology, 1995
- Identification of Human and Mouse p19, a Novel CDK4 and CDK6 Inhibitor with Homology to p16ink4Molecular and Cellular Biology, 1995
- Principles of CDK regulationNature, 1995
- Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active form of the Retinoblastoma Gene ProductScience, 1995
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993